22Nd Century Stock Price, News & Analysis

22nd Century Group (Nasdaq: XXII) announced a partnership with Eagle Rock Distributing to launch its VLN® reduced nicotine cigarettes across Colorado starting September 2022. This collaboration aims to distribute VLN® to thousands of locations, including regional and national chains and independent retailers. VLN® cigarettes contain approximately 95% less nicotine, addressing health concerns associated with conventional smoking. The partnership follows a successful pilot program in Chicago, which showed high customer recommendation rates for VLN®. This initiative is aligned with the FDA's proposed nicotine cap to reduce smoking.

22nd Century Group (Nasdaq: XXII) aligns with the FDA and the Biden Administration's initiative to reduce nicotine content in cigarettes, aiming to help smokers cut down. Their VLN® reduced nicotine content cigarettes are designed to aid smokers in reducing their nicotine intake, with plans for expanded sales in Chicago following successful pilot results. The FDA's proposed actions could significantly impact public health, potentially helping over 5 million people quit smoking. These initiatives address the high addiction rates linked to nicotine and the associated health risks, including cancer.

22nd Century Group, Inc. (Nasdaq: XXII) announced the appointment of Lucie S. Salhany to its Board of Directors on September 12, 2022. Salhany, a renowned media executive with a history of successful product launches, will enhance the company's focus on tobacco harm reduction and its hemp/cannabis initiatives. Her experience includes being the first woman chair of a major broadcast network, and she will serve on the Corporate Governance and Finance committees. Board Chair Nora B. Sullivan and CEO James A. Mish expressed confidence in her ability to elevate the company's market profile.

22nd Century Group (Nasdaq: XXII) announced significant management changes aimed at accelerating growth in its reduced nicotine content tobacco business. Michael Zercher, President and COO, will depart by September 30, 2022, while John Miller will take over the tobacco-related duties. CEO James A. Mish will also assume the title of Corporate President. The company reported successful pilot results for its VLN® reduced nicotine tobacco product, paving the way for expanded sales and market rollouts across the U.S. This strategic shift is designed to enhance coordination for upcoming product launches.

22nd Century Group, Inc. (XXII) is expanding its VLN® tobacco sales in September, targeting additional stores in Illinois and launching in Colorado through new distribution partnerships. VLN® cigarettes contain 95% less nicotine than traditional cigarettes, promoting a non-addictive smoking option. Partnerships with major retailers like Circle K and Smoker Friendly® will enhance product availability, adding thousands of additional points of sale. The company's strong pilot results in Chicago indicate high demand, aiming to capture a significant share of the $80 billion U.S. tobacco market.

22nd Century Group, Inc. (Nasdaq: XXII) announces that its reduced nicotine content cigarettes, VLN® King and VLN® Menthol King, received the Best New Product award in the cigarette category from Convenience Store News. This recognition reflects consumer demand for alternatives to traditional cigarettes. The company plans to expand its VLN® launch, currently a pilot in Chicago, across Colorado. The Best New Products Awards highlight innovative products in the convenience sector, with judging based on various consumer preferences.

22nd Century Group (Nasdaq: XXII) announced the successful pilot of its VLN® cigarettes in Chicago, which have 95% less nicotine and are FDA-authorized to help smokers reduce consumption. Following positive results, the company plans to expand sales to Colorado. This launch marks a significant step in tobacco harm reduction and positions VLN® as a unique product in the market.

22nd Century Group, Inc. (XXII) reported a strong Q2 2022, with net sales of $14.5 million, up 73% year-over-year. The company exceeded expectations with its VLN® pilot in Chicago, prompting an accelerated launch in Colorado. The recent acquisition of GVB Biopharma is expected to double corporate revenue, enhancing their hemp/cannabis capabilities. The balance sheet was strengthened by a $35 million equity offering. Despite these gains, the operating loss widened to $(10.5 million), and net loss was $(11.5 million) with a net loss per share of $(0.06).

22nd Century Group (XXII) announced a live webcast on August 9, 2022, to discuss its Q2 2022 results. The session is set for 10:00 AM ET, following a press release at 6:00 AM ET. CEO James A. Mish and other executives will review financial outcomes and advancements across the company’s tobacco, hemp/cannabis, and hops sectors. The webcast will include a Q&A session for analysts and interested stakeholders. More information and access to the webcast can be found on the company’s investor relations webpage.